"To Boldly Go Where No One Has Gone Before".

Americans are suffering from a culture of taking pills. Six out of ten Americans utilize at least one prescription drug, and more than one in ten use five or more prescription medicines. Although this torrent of taking pills is already high, drug use in the USA has not yet crested. Prescription drugs have specific targets, but often they adversely affect other tissues and organs. In keeping with the mission of the recently named National Center for Complementary and Integrative Health (NCCIH), Brain, Behavior, and Immunity searches for the underlying cause and potential efficacy of both drug and non-drug interventions. When the journal was first published in 1987, it challenged the scientific tidal wave that emphasized specialization in a single, specific discipline such as molecular biology, neuroscience or immunology. The focus of the journal was to support and extend biomedical research by publishing cutting edge findings in psychoneuroimmunology. Brain, Behavior, and Immunity began serving as the official journal of the Psychoneuroimmunology Research Society (PNIRS) in 2000. During its first 16 years of existence, Brain, Behavior, and Immunity published 600 papers. During the subsequent 15 years, there has been a steep, linear rise in publications that continues to this day, amounting to the publication of nearly 2,500 articles in psychoneuroimmunology. Some of the current and hottest topics in the field are investigating ancient health practices such as mindfulness-based meditation, Tai Chi, exercise, perinatal health and the gut microbiome. As such, Brain, Behavior, and Immunity continues to advance biomedical research by boldly going forward. Just as it originally challenged the specialization philosophy that is so prevalent in medicine, it is now exploring the integrative physiological events that underlie century-old health practices. This approach has revealed that some age-old interventions are just as efficacious as prescription drugs. A world in which century-old therapies meet modern technologies could well be the best medicine for all of us.

Copyright © 2017. Published by Elsevier Inc.

PMID: 28818559 DOI: 10.1016/j.bbi.2017.08.013